Delivery Order 36F79720D0189-36C26124N0381
Award Date
1/12/24
Potential Completion Date
3/12/24
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Incyte Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Talleyville, DE 19803, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Incyte Corporation was awarded a $12,725.23 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to supply 13.5mg Pemigatinib tablets. The order was issued against Incyte's Pharmaceuticals and Drugs Federal Supply Schedule contract to fulfill a request for the specialized cancer medication. With no set aside designation applied, Incyte will deliver the Pemigatinib tablets as the prime contractor under a firm fixed price...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725 delivery order contract to Incyte Corporation. Under the terms of the contract, Incyte will provide Pemigatinib to the VA network through January 2024. The contract was awarded against Incyte's Pharmaceuticals and Drugs schedule (FSS-61-IB) master agreement with the General Services Administration. Pemigatinib will be delivered to the VA network's location in Talleyville,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $63,626.15 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule. The firm fixed price order is for PEMAZYRE 13.5, with performance in West Haven, Connecticut and a completion date of April 10, 2022. The contract utilizes Master GSA Schedule FSS-61-IB and has no set-aside designation. Incyte will provide cancer treatment drugs to support...
Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order, which has no set aside designation and completion date of October 30, 2020, is for the provision of PEMAZYRE to treat patients. The firm fixed price order was awarded on October 5, 2020 under Incyte's master GSA Schedule contract vehicle. The place...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $12,725.23 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The firm fixed price order is for PEMAZYRE 9 MG tablets to fulfill requirements through September 30th, 2022. Place of performance will be Incyte Corporation's location in West Chester Township, Ohio. No set-aside designation was applied to this order to...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21, is for the emergency provision of 4.5mg Pemigatinib tablets to treat eligible veterans. The $12,725.23 firm fixed price contract was awarded on June 13, 2023 to Incyte Corporation of Talleyville, Delaware and has a period of performance through July 13, 2023. No set-aside designation was applied...
The Department of Veterans Affairs Veterans Health Administration awarded Incyte Corporation a $556.97 million firm fixed price delivery order against their Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide PEMAZYRE 9MG tablets to VHA facilities in Veterans Integrated Service Network 15. The place of performance is Incyte's location in Talleyville, Delaware and the period of performance runs from November 2020 through November 2021. No set aside designation or...
Incyte Corporation has been awarded a $12,811.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for PEMIGATINIB/PEMAZYRE 9MG TAB to be delivered to a location in Fresno, California by May 22, 2023. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB to supply pharmaceutical products and drugs in...
Incyte Corporation was awarded a $13,290.97 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply pharmaceutical products under the Pharmaceuticals and Drugs Federal Supply Schedule. The order was issued against Incyte's FSS-61-IB schedule contract for the delivery of pharmacy items to the Talleyville, Delaware location. Incyte will fulfill the order as the prime contractor on a firm fixed price basis by the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $12,725.23 firm fixed price call against the Pharmaceuticals and Drugs Federal Supply Schedule to Incyte Corporation for the delivery of PEMAZYRE tablets. The contract has a completion date of September 5, 2021 and was awarded on August 6, 2021 without a set-aside designation. Under this contract, Incyte Corporation will provide the requested pharmaceutical products to support...